Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study
IA can be considered as a relatively safe and effective adjuvant therapy for patients with severe or refractory BP.
Authors
- Nina van Beek (ORCID: https://orcid.org/0000-0002-3265-0011)
- Michael Kasperkiewicz
- Nina Schumacher (ORCID: https://orcid.org/0000-0003-2542-7353)
- Enno Schmidt (ORCID: https://orcid.org/0000-0002-1206-8913)
- Philip Muck
- Maike M. Holtsche (ORCID: https://orcid.org/0000-0002-5318-5796)
- Artem Vorobyev (ORCID: https://orcid.org/0000-0002-1542-0732)
- Christoph M. Hammers
Institutions
- Carl von Ossietzky Universität Oldenburg (DE)
- University of California, Los Angeles (US)
- Klinikum Oldenburg (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1111/ddg.15909
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00